Fatal Neuroleptic Malignant Syndrome Associated With Quetiapine

被引:8
|
作者
Schattner, Ami
Kitroser, Ella
Cohen, Joel D.
机构
[1] Kaplan Med Ctr, Dept Med, Rehovot, Israel
[2] Hebrew Univ Hadassah Med Sch, Jerusalem, Israel
关键词
quetiapine; neuroleptic malignant syndrome; adverse drug reaction;
D O I
10.1097/MJT.0000000000000274
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute psychosis developed in an elderly patient with Parkinson disease and she was admitted and treated with quetiapine (Seroquel). One day later, high fever unexplained by infection appeared associated with restlessness, confusion, convulsion, leukocytosis, and extreme serum creatine kinase levels. She died of neuroleptic malignant syndrome (NMS) despite intensive treatment. Quetiapine is an atypical neuroleptic agent, rarely associated with NMS in the absence of other contributing drugs. Our case strongly establishes quetiapine-induced NMS (Naranjo scale 6) and is also unique in the abrupt onset and severe refractory course. The steep increase in the prescription of quetiapine worldwide mandates better recognition of this severe adverse reaction, which is fortunately rare, to allow immediate drug withdrawal and appropriate treatment.
引用
收藏
页码:E1209 / E1210
页数:2
相关论文
共 50 条
  • [31] Atypical Neuroleptic Malignant Syndrome With Quetiapine A Case Report and Review of the Literature
    El-Gaaly, Sherief
    John, Philip St.
    Dunsmore, Sara
    Bolton, James M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (05) : 497 - 499
  • [32] QUETIAPINE INDUCED ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME AND HYPEROSMOLAR HYPERGLYCEMIC STATE
    Yeung, Siu Yan Amy
    Lee, Sue
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [33] Neuroleptic malignant syndrome and quetiapine (vol 159, pg 149, 2002)
    Sing, KJ
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (05): : 892 - 892
  • [34] NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH PROCHLORPERAZINE
    MANSER, TJ
    WARNER, JF
    SOUTHERN MEDICAL JOURNAL, 1990, 83 (01) : 73 - 74
  • [35] Neuroleptic malignant syndrome associated with olanzapine
    Filice, GA
    McDougall, BC
    Ercan-Eang, N
    Billington, CJ
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (11) : 1158 - 1159
  • [36] NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH METOCLOPRAMIDE
    ROBINSON, MB
    KENNETT, RP
    HARDING, AE
    LEGG, NJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (12): : 1304 - 1304
  • [37] Neuroleptic malignant syndrome associated with nortriptyline
    June, R
    Yunus, M
    Gossman, W
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1999, 17 (07): : 736 - 737
  • [38] NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH METOCLOPRAMIDE
    CASSIDY, T
    BANSAL, SK
    BRITISH MEDICAL JOURNAL, 1988, 296 (6616): : 214 - 214
  • [39] Neuroleptic malignant syndrome associated to olanzapine
    López, MMG
    Ciprés, L
    de Cendra, E
    Franch, JV
    MEDICINA CLINICA, 1999, 113 (06): : 239 - 239
  • [40] Neuroleptic malignant syndrome associated with metoclopramide
    Nonino, F
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (05) : 644 - 645